Effect of Cognitive Training on Gait in Parkinson's Disease
Parkinson Disease
About this trial
This is an interventional treatment trial for Parkinson Disease focused on measuring Parkinson Disease, Cognitive training, Gait
Eligibility Criteria
Inclusion Criteria:
- diagnosis of Parkinson´s disease (PD)
- PD duration ≥8 years
- mild cognitive impairment
- stable medication
- presence of freezing of gait according to the FoG-Q AND/OR Rapid Turns Test
Exclusion Criteria:
- dementia
- deep brain stimulation, pump therapy with Duodopa or Apomorphine
- severe fluctuations with ON state duration for less than 2 hours
- dopa dysregulation syndrome
- impulse control disorder
- untreated depression
- benzodiazepines except for single dose at night
- non-compliance
- inability to walk without support
- significant co-morbidities likely to affect gait, e.g., acute illness, orthopedic disease, significant visual problems, or a clinical history of stroke
- involvement in other treatment trials
- not meeting inclusion criteria
Sites / Locations
- General University Hospital in Prague
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Group cognitive training
Home-based cognitive training
The experimental group will undergo 60 minutes long cognitive training group sessions twice a week for 12 weeks focused on executive function, attention and working memory.
The control group will perform executive function, attention and working memory training similar to the experimental group but at home as instructed by their therapist using specialized software for cognitive training (Rehacom). This training will be dose matched to the experimental group, i.e. it will be performed four times a week for 30 minutes for 12 weeks. In this group, therapists will only provide coaching once a month.